An empowered MSSG will allow the EU to address medicine shortages by enforcing drug sharing between member states. Credit: Frankie Fattorini/ GlobalData Earlier this month,
Clinical operations teams can expect a tremendous return on investments in artificial intelligence (AI) in the next 5–10 years, according to speakers from pharmaceutical and
Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients
The Vietnamese Government is aiming to attract overseas investment to encourage domestic drug development, manufacturing, and commercialisation through the latest amendment of its 2016 Law
Ribopro focuses on the development and manufacture of mRNA and LNPs. Credit: Volha_R/Shutterstock. ImmunoPrecise Antibodies (IPA) has entered a strategic partnership with Ribopro to transform
In late 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) for sickle cell disease (SCD), marking the world’s
Odronextamab is a CD20×CD3 bispecific antibody. Credit: FatCamera via Getty Images. Regeneron Pharmaceuticals is taking another shot at US Food and Drug Administration (FDA) accelerated
Two clinical trials involving the ADC are currently recruiting subjects. Credit: PeopleImages.com – Yuri A/Shutterstock. The US Food and Drug Administration (FDA) has granted fast
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS